Tomorrow's Health, Today's Research

Dr. Juan Ausio

Professor, Biochemistry/Microbiology Department
This e-mail address is being protected from spambots. You need JavaScript enabled to view it. This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Phone: (250) 721-8863
Department Page
Research area: chromatin assembly and transcription
_______________________________________________________________________________

Research Profile:

Deciphering the histone code

Dr. Juan Ausio wonders if Edgar and Ellen Stedman ever turn in their graves. Just before Watson and Crick uncovered the structure of DNA in the ‘50s, people still weren’t sure what type of material coded genes; some thought it was DNA, others favoured proteins. The Stedmans proposed that a type of proteins called histones were complex enough to contain a code – an idea that seemed ludicrous once people deciphered the code in DNA.

It turns out this husband and wife team was partially right. In what is now a hot area of research, many researchers believe there is a “histone code” – a meta code that controls when and where the underlying DNA code is read.

To back up a little, it may help to understand the structure of chromosomes. While most people are familiar with the double helix, fewer people are familiar with the term “beads on a string.” That is how geneticists describe the way the double helix spools around a cluster of histones. The “beads” are DNA wrapped around histones, which are separated by short sections of bare DNA that looks like string. Together the histones and DNA are known as chromatin, which gets further wrapped and compacted to form chromosomes. Genes are only expressed when histones relax their hold on the DNA so that sections of DNA become exposed.

Ausio has never lost faith that histones are important for controlling gene expression, even when most people thought histones were nothing more than a scaffold to pack DNA into cells. Ausio began his work on histones in the ‘70s during his PhD at the University of Barcelona in his native Spain. At that time, people didn’t even know the basic “beads on a string" structure of chromatin, and Ausio admits that only nerds were interested in learning the biophysical techniques needed to solve the structure.

By the time Ausio began studying the structure of chromatin at UVic in 1990, he was interested in changes that occur to histones (they become acetylated) just before genes are read. He wanted to know acetylation plays a role with switching on and off genes.

Using biophysical techniques such as analytical ultracentrifuge and circular dichroism spectroscopy, Ausio uncovered the physical characteristics of chromatin, especially how its stability and structure change when histones are acetylated. He purified and characterized proteins that bind to DNA and histones to figure out if these proteins could be signals for gene expression. He also discovered several histone-like proteins that only show up when sperm are formed. These histone variants pack DNA differently, locking down many genes from being expressed in sperm.

Sometimes it was a lonely field. Few researchers had the patience to stick to what was a tricky problem: histones are relatively homogenous, so how can the cell tell which histones to acetylate? In other words, how does the cell know which histones are associated with which genes?

Everything changed in the mid-'90s when well-known chromatin biologist David Allis realized that transcription factors that bind to DNA, also acetylate histones. Now it’s known that histones can undergo several chemical alterations that act as tags, such as acetylation, phosphorylation, and methylation. These tags can alternate along a tail of 30 amino acids at the end of each histone to give millions of combinations, in other words, a code. The code controls gene expression.

Now researchers talk about “histone writers” referring to the enzymes that tag histones, and “histone readers,” referring to proteins that respond to the code. In fact, Ausio says “the histone code could be as important as the DNA code itself.”

These days Ausio finds himself at the centre of an exceedingly popular field where most major drug companies are pursuing histone-related therapies. The applications are wide ranging from cancer to almost any other type of genetic disease.

Ausio has also turned to more applied research, looking at the role of histones in prostate cancer and breast cancer: he believes the histone code can go awry telling the cell to express certain genes at the wrong time.

Ausio is also part of a group of Victoria researchers working on Rett syndrome. Rett syndrome is a neural developmental disorder in girls caused by a mutation in MeCP2, a protein that interacts with chromatin. When MeCP2 is mutated it causes genes to turn on abnormally.

Ausio is working with the Medical Genetics department at the Victoria General Hospital to identify different gene mutations involved in Rett syndrome in local patients and study the interactions of this protein with chromatin. They hope to come up with a treatment based on understanding how the mutations disrupt the normal pattern of gene expression.

 

 

The leg bone is connected to the arm bone

How does the nervous system coordinate the arms and legs during walking? Professor Dr. E. Paul Zehr has expanded the focus of neuroscientists studying motor control, leading to new treatments for stroke victims. More

Poxvirus expert creates bioinformatics tools

Dr. Chris Upton bridges gap between genetics and computers with the Viral Bioinformatics Resource Center. More

An eye for detail

Dr. Jim Tanaka, a cognitive neuroscientist, is examining whether autistic children can be taught to overcome "face blindness" by engaging a part of their brains, which they use to expertly recognize other objects. More

A new way to look for cancer biomarkers

Dr. Terry Pearson is banking on mass spectrometry to be the next big thing for antibody-based diagnosis. More

Elegant strategy works against broad range of cancers

Dr. Brad Nelson thinks the time is right for T cell therapy. More

Why nicotine is addictive, yet good for the brain

Neuroscientist Dr. Raad Nashmi found a new pathway for nicotine addiction, which also helps explain nicotine’s benefits for those prone to Parkinson’s. More

Tracking genetic disorders

Whether he is finding a genetic cure or tracking a rare mutation, Dr. Patrick Macleod is a vital link between patients and molecular researchers at the CBR. More

 

Bringing the power of genomics to aquaculture

Dr. Ben Koop co-founded the consortium for Genomic Research on All Salmon Project (cGRASP), an international team devoted to understanding salmon from its DNA out: its evolutionary history, its ecology, its health. More

Speed up and lighten up

Neuroscientist Dr. Sandra Hundza explores ways to teach people to walk again after a neurotrauma like a stroke or spinal cord injury, based on understanding the neural patterns that control rhythmic movement

Listening to cells talk

The field of signal transduction is fulfilling its early promise of cancer cures. Professor Dr. Perry Howard is looking for signals to kill cancer cells. More

Learning, Dopamine and ADHD

Subheadline for CBR front page flash: Cognitive neuroscientist Dr. Clay Holroyd is rephrasing the symptom of “inability to focus” to “an inability to get the appropriate dopamine reward for focus.” More

The promise of synthetic molecules for controlling proteins

If you can’t find the right chemical tool to suit your medical research, you could ask chemist Dr. Fraser Hof to build one. Histone experts eye up Hof’s latest: a synthetic molecule that binds histones, disrupting a gene regulation pathway. More

A better way to test for pollutants

Forty years after Rachel Carson wrote Silent Spring, Dr. Caren Helbing’s work warns us that we still don’t really know how to test for chemical contaminants in the environment. More

CBR founder tackles risks and ethics

Dr. Barry Glickman helps Health Canada and the Canadian Space Agency sort through the hype to find the real potential — and threats — of nanotechnology. More

Order in the chaos

Dr. Roderick Edwards finds patterns invisible to the naked eye, as he seeks for order in systems as complex as neuronal nets. More

Salmon genome gives clues to evolution

Dr. Johan de Boer describes how a salmon ancestor diverged so quickly into dozens of species thanks to transposons. More
 

Exercise reverses fetal alcohol syndrome (FAS)

Dr. Brian Christie was one of the first neuroscientists to discover that exercise promotes the generation of new brain cells. In his latest research, he found that exercise can even reverse FAS-related brain damage. More

The heartbreak of tracking rare mutations

Dr. Francis Choy's study of inherited diseases has immediate impact on patients. More

Watching eyes grow

Dr. Robert Chow is finding genes that control eye development. More

Syphilis expertise leads to whale research

When Dr. Caroline Cameron is not studying syphilis, she’s catching snot from whales: the strange path from syphilis to marine biology. More

Sea urchin sequence accelerates discoveries

Dr. Robert Burke has seen developmental biology grow up and zoom in. When he helped finish the sea urchin sequence in 2006, the field took another quantum leap forward. More

Deciphering the Histone Code

Dr. Juan Ausio helped figure out the structure and nature of chromatin, which led to the idea of a histone code. More